
In Obese Mice, Molecule Reversed Nearly All Pathways Activated In Mice By High Calorie Diets
Findings Suggest Broad Implications for the Treatment of Age-related Diseases, Including Diabetes and Heart Disease
"Mice are much closer evolutionarily to humans than any previous model organism treated by this molecule, which offers hope that similar impacts might be seen in humans without negative side-effects," says co-senior author David Sinclair, HMS associate professor of pathology, and co-director of the Paul F. Glenn Labs for the Biological Mechanisms of Aging.
"After six months, resveratrol essentially prevented most of the negative effects of the high calorie diet in mice," said Rafael de Cabo, Ph.D., the study's other co-senior investigator from the National Institute on Aging's Laboratory of Experimental Gerontology, Aging, Metabolism, and Nutrition Unit. "There is a lot of work ahead that will help us better understand resveratrol's roles and the best applications for it."
Image of three 15 month old mice: (left) high calorie diet + resveratrol; (center) high calorie diet; (right) standard diet. Photo by Doug Hansen.
Resveratrol is found in red wines and produced by a variety of plants when put under stress. It was first discovered to have an anti-aging properties by Sinclair, other HMS researchers, and their colleagues in 2003 and reported in Nature. The 2003 study showed that yeast treated with resveratrol lived 60 percent longer. Since 2003, resveratrol has been shown to extend the lifespan of worms and flies by nearly 30 percent, and fish by almost 60 percent. It has also been shown to protect against Huntington's disease in two different animal models (worms and mice).
"The "healthspan" benefits we saw in the obese mice treated with resveratrol, such as increased insulin sensitivity, decreased glucose levels, healthier heart and liver tissues, are positive clinical indicators and may mean we can stave off in humans age-related diseases such as type 2 diabetes, heart disease, and cancer, but only time and more research will tell," says Sinclair, who is also a co-founder of Sirtris, a company with an author on this paper and which is currently in a phase 1b trial in humans with diabetes using an enhanced, proprietary formulation of resveratrol. [Harvard has license and equity interests with Sirtris, which is not a public company.]
Investigators identified resveratrol while looking for compounds that activate Sir2, an enzyme linked to lifespan extension in yeast and other lower organisms. For the last 70 years, scientists have been able to increase the lifespan of a variety of species by reducing their normal food consumption by 30 to 40 percent - a diet known as calorie restriction. Through this research, scientists identified Sir2 as a key contributor to life extension. Without Sir2, for example, fruit flies see none of the benefits from either calorie restriction or treatment by resveratrol. The mammalian version of the Sir2 gene is SIRT1, which has the same enzymatic activity as Sir2, but modifies a wider variety of molecules throughout cells. Indicators in this study show that resveratrol might also be activating SIRT1 in mice, as well as other known longevity pathways.
How the Study Was Done
Survival Benefit
Reversing Genetic Pathways Triggered by High Calorie Diet
Improved Health Biomarkers: Glucose and Insulin
Organ Protection: Heart and Liver
Links to Calorie Restriction Lifespan Model
Links to SIRT1
How the Study Was Done
This study examined three groups of mice, one on a standard diet
(SD), another on a high calorie diet (HC) with 60 percent of calories
coming from fat, and a third group of mice on the same high calorie
diet but also treated with resveratrol (HCR). At middle age, or
roughly 52 weeks of life, the researchers put the mice on the
different diets.
Survival Benefit
At 60 weeks of age, the survival rates of HC and HCR fed mice groups
began to diverge and remained separated by a three to four month
span. At 114 weeks of age, 58 percent of the HC fed mice had died,
compared to 42 percent of the HCR and SD groups. Presently, the team
has found resveratrol to reduce the risk of death from the HC diet by
31 percent, to a point where it is not significantly increased over
the SD group.(Note: Given that mice are still living, final
calculations can't be made.) "The median lifespan increase we are
seeing is about 15 percent at this point," says Sinclair. "We won't
have final lifespan numbers until all of the mice pass away, and this
particular strain of mouse generally lives for two-and-a-half-years.
So we are around five months from having final numbers, but there is
no question that we are seeing increased longevity.
The team also found that the HCR fed mice had a much higher quality
of life, outperforming the HC fed mice on motor skill tests. "The
mice on resveratrol have not been just living longer," says Sinclair.
"They are also living more active, better lives. Their motor skills
actually show improvement as they grow older."
The resveratrol fed mice also showed improved motor function with age over its HC fed counterparts. Researchers watched how well the mice did walking on a rotarod, similar to walking on a log in the water, a common measure of balance and motor coordination. At 24 months of age, the HC fed group would fall off the rotarod after 60 seconds, while the HCR group would stay on for nearly 120 seconds. The HCR group steadily improved their motor skills as they aged to the point where they were indistinguishable from the SD fed group.
Reversing Genetic Pathways Triggered by High Calorie Diet
The research team also wanted to see if resveratrol could reverse the
changes in gene expression patterns triggered by high calorie diets.
Using liver tissue of five mice at 18 months of age from each group,
the team performed a whole-genome microarray and identified which
genes were turned on or off. The researchers then used a database
generated by the Broad Institute that groups individual genes into
common functional pathways to see where there were major differences.
"We made a striking observation," says Sinclair. "Resveratrol opposed the effects of high caloric intake in 144 out of 153 significantly altered pathways. In terms of gene expression and pathway comparison, the resveratrol fed group was more similar to the standard diet fed group than the high calorie group."
Improved Health Biomarkers: Glucose and Insulin
In humans, high calorie diets can increase glucose and insulin levels
leading to diabetes, cardiovascular disease, and non-alcoholic fatty
liver disease. In the HC fed mice, researchers found biomarkers that
might predict diabetes, including increased levels of insulin,
glucose and insulin-like growth factor-1 (IGF-1). Conversely, the
HCR fed group had significantly lower levels of these markers,
paralleling the SD group. For example, a standard diabetes glucose
test on the HCR fed group found considerably higher insulin
sensitivity, meaning the HCR group had a lower disposition toward
diabetes than the HC fed group. Lower insulin levels also predict
increased lifespan in mice.
Organ Protection: Heart and Liver
Three pathologists examined heart tissue from the SD, HC, and HCR
mice, and while not knowing which organ belonged to which mouse
group, they looked for subtle changes in the abundance of fatty
lesions, degeneration and inflammation. On a relative scale of 0-4,
the assessment produced mean scores of 1.6 for the SD group, 3.2 for
the HC group, and 1.2 for the HCR group.
The researchers also found that the livers of mice at 18 months of
age on the HC diet were greatly increased in size and weight. Liver
tissue studies of these mice showed a loss of cellular integrity, and
a build-up of lipids, which is common to high fat diets. In contrast,
the HCR group had normal, healthy livers.

Livers of mice at 18 months old: (left) normal diet; (center) high calorie diet; (right) high calorie diet + resveratrol.
Links to Calorie Restriction Lifespan Model
The researchers also looked for metabolic ties to resveratrol's
impact: pathway changes that mimicked those caused by calorie
restriction. They examined AMP-activated kinase (AMPK), a metabolic
regulator that promotes insulin sensitivity and fatty acid oxidation.
It's been shown in previous work that the lifespan of worms has been
extended by the addition of copies the AMPK gene, and chronic
activation of AMPK is seen on calorie-restricted diets. The
researchers examined the livers of the HCR fed group and found a
strong tendency for AMPK activation, as well as two downstream
indicators of its activity.
Calorie restriction and exercise have also been previously shown to increase the number of mitochondria in the liver. Mitochondria generate energy in cells. Through electron microscopy, investigators showed that the livers of the HCR fed mice had considerably more mitochondria than the HC group, and were not significantly different from those of the SD group.
Links to SIRT1
The team also asked if SIRT1 was activated by resveratrol in mice, as
Sir2 is in lower organisms. To determine this, they looked at the
amount of a specific chemical modification (acetylation) on the
molecule PGC-1alpha. Removal of the "acetyl" chemical groups on
PGC-1alpha activates this protein so that it can turn on certain
genes that generate mitochondria and turn muscle into the type suited
for endurance. The only enzyme known to remove the acetyl chemical
groups on PGC-1alpha is SIRT1, and therefore the activity of
PGC-1alpha is one of the most reliable and specific markers of SIRT1
activity in mammals. The research team found that levels of
PGC-1alpha were three-fold lower in the HCR fed mice than in the HC
mice, consistent with what would be expected when SIRT1 was being
activated by resveratrol.
"This work demonstrates that there may be tremendous medical benefits to unlocking the secrets behind the genes that control our longevity," says Sinclair, "No doubt many more remain to be discovered in coming years."
This study was supported by Paul F. Glenn and the Glenn Foundation for Medical Research, the U.S. National Institutes of Health and the National Institute on Aging, the Ellison Medical Research Foundation, the American Heart Foundation, and the American Diabetes Association.
For more information on diabetes, visit the Harvard Medical School
Consumer Information page Diabetes. For updates on this topic, click
to subscribe.
Contact:
John Lacey, Harvard Medical School, 617-432-0442 (public_affairs@hms.harvard.edu)